Quantcast

Posts Tagged ‘Viralytics Ltd.’

Viralytics Ltd. (VRACY: OTCQX International) | Change of Director’s Interest Notice

Viralytics Ltd. (VRACY: OTCQX International) | Appendix 3B

Viralytics Ltd. (VRACY: OTCQX International) | Appendix 3B

Viralytics Ltd. (VRACY: OTCQX International) | Viralytics moves into the Expansion Phase and Reports on Progress in the CAVATAK® and KEYTRUDA® Combination KEYNOTE-200 clinical trial at AACR Conference

Viralytics Ltd. (VRACY: OTCQX International) | Viralytics’ CAVATAK® in Combination with YERVOY® Provides Promising Results in Advanced Melanoma from the Phase 1b MITCI clinical study

Viralytics Ltd. (VRACY: OTCQX International) | Viralytics’ CAVATAK® in Combination with KEYTRUDA® Provides Promising Results in the CAPRA Melanoma Clinical Trial

Viralytics Ltd. (VRACY: OTCQX International) | Form 603 – Notice of Initial Substantial Shareholder

Viralytics Ltd. (VRACY: OTCQX International) | Viralytics to Present New CAVATAK Clinical Data at AACR

Viralytics Ltd. (VRACY: OTCQX International) | Semi-Annual Report

Viralytics Ltd. (VRACY: OTCQX International) | Viralytics Receives $4.3 Million R&D Tax Incentive